RU2118527C1 - Фармацевтическая композиция, содержащая алкилсульфонамид-агонист 5ht1, для ректального введения - Google Patents

Фармацевтическая композиция, содержащая алкилсульфонамид-агонист 5ht1, для ректального введения Download PDF

Info

Publication number
RU2118527C1
RU2118527C1 RU94046069/14A RU94046069A RU2118527C1 RU 2118527 C1 RU2118527 C1 RU 2118527C1 RU 94046069/14 A RU94046069/14 A RU 94046069/14A RU 94046069 A RU94046069 A RU 94046069A RU 2118527 C1 RU2118527 C1 RU 2118527C1
Authority
RU
Russia
Prior art keywords
methyl
active ingredient
indole
composition
composition according
Prior art date
Application number
RU94046069/14A
Other languages
English (en)
Russian (ru)
Other versions
RU94046069A (ru
Inventor
Мерле Надин (FR)
Мерле Надин
Ришар Изабелль (FR)
Ришар Изабелль
Тиелеман Изабелль (FR)
Тиелеман Изабелль
Original Assignee
Лаборатуар Глаксо С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лаборатуар Глаксо С.А. filed Critical Лаборатуар Глаксо С.А.
Publication of RU94046069A publication Critical patent/RU94046069A/ru
Application granted granted Critical
Publication of RU2118527C1 publication Critical patent/RU2118527C1/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
RU94046069/14A 1992-05-07 1993-05-03 Фармацевтическая композиция, содержащая алкилсульфонамид-агонист 5ht1, для ректального введения RU2118527C1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929209882A GB9209882D0 (en) 1992-05-07 1992-05-07 Compositions
GB9209882.1 1992-05-07

Publications (2)

Publication Number Publication Date
RU94046069A RU94046069A (ru) 1997-11-27
RU2118527C1 true RU2118527C1 (ru) 1998-09-10

Family

ID=10715158

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94046069/14A RU2118527C1 (ru) 1992-05-07 1993-05-03 Фармацевтическая композиция, содержащая алкилсульфонамид-агонист 5ht1, для ректального введения

Country Status (33)

Country Link
US (1) US5705506A (enExample)
EP (1) EP0639072B1 (enExample)
JP (1) JPH07506570A (enExample)
KR (1) KR100253111B1 (enExample)
AT (1) ATE163850T1 (enExample)
AU (1) AU670083B2 (enExample)
BE (1) BE1007024A5 (enExample)
BG (1) BG62120B1 (enExample)
BR (1) BR1100108A (enExample)
CA (1) CA2135179C (enExample)
CH (1) CH685920A5 (enExample)
CY (1) CY2039B1 (enExample)
CZ (1) CZ283512B6 (enExample)
DE (1) DE69317418T2 (enExample)
ES (1) ES2113533T3 (enExample)
FR (1) FR2690847B1 (enExample)
GB (2) GB9209882D0 (enExample)
GR (1) GR3026584T3 (enExample)
HK (1) HK95697A (enExample)
HU (2) HU227338B1 (enExample)
IE (1) IE75203B1 (enExample)
IL (1) IL105468A (enExample)
IT (1) IT1261471B (enExample)
NO (1) NO306700B1 (enExample)
NZ (1) NZ252132A (enExample)
OA (1) OA10109A (enExample)
RO (1) RO112993B1 (enExample)
RU (1) RU2118527C1 (enExample)
SG (1) SG46649A1 (enExample)
TW (1) TW231970B (enExample)
UA (1) UA37206C2 (enExample)
WO (1) WO1993021916A1 (enExample)
ZA (1) ZA933178B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2423360C2 (ru) * 2005-10-14 2011-07-10 Атерсис, Инк. Производные индола как ингибиторы н3-рецептора гистамина для лечения когнитивных расстройств и нарушений сна, ожирения и других расстройств центральной нервной системы

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997044062A1 (en) * 1996-05-23 1997-11-27 Alcon Laboratories, Inc. The use of 5-ht1b/1d agonists to treat ocular pain
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
ID27825A (id) * 1998-03-26 2001-04-26 Fujisawa Pharmaceutical Co Sediaan lepas lambat
WO2000051624A2 (en) * 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Methods and compositions useful in inhibiting apoptosis
JP2010522135A (ja) 2006-10-09 2010-07-01 チャールストン ラボラトリーズ，インコーポレイテッド 医薬組成物
JP5714910B2 (ja) 2008-01-09 2015-05-07 チャールストン ラボラトリーズ，インコーポレイテッド 薬学的組成物
EP3311667A1 (en) 2009-07-08 2018-04-25 Charleston Laboratories, Inc. Pharmaceutical compositions
CA2813648C (en) 2010-10-15 2019-06-25 Concit Pharma Aps Combinations of serotonin receptor agonists for treatment of movement disorders
CA2870123C (en) 2012-04-18 2021-02-23 Contera Pharma Aps Orally available pharmaceutical formulation suitable for improved management of movement disorders
US10179109B2 (en) 2016-03-04 2019-01-15 Charleston Laboratories, Inc. Pharmaceutical compositions comprising 5HT receptor agonist and antiemetic particulates
KR102443161B1 (ko) 2016-07-11 2022-09-14 콘테라 파르마 에이/에스 아침 운동 불능을 치료하기 위한 박동성 약물 전달 시스템

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
GB2082175B (en) * 1980-08-12 1984-05-02 Glaxo Group Ltd Heterocyclic compounds
NZ197998A (en) * 1980-08-12 1985-08-16 Glaxo Group Ltd 5-amino(methyl)-1h-indol-3-ylalkaneamines
GR79215B (enExample) * 1982-06-07 1984-10-22 Glaxo Group Ltd
GB8332435D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
IT1181741B (it) * 1984-12-04 1987-09-30 Glaxo Group Ltd Derivati di indolo,procedimento per prepararli e composizioni farmaceutiche che li contengono
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
EP0225726B1 (en) * 1985-11-08 1991-04-17 Glaxo Group Limited Indole derivatives
KR0131327B1 (en) * 1987-08-13 1998-04-17 Glaxo Group Ltd Indole derivatives
US5399574A (en) * 1990-06-07 1995-03-21 Burroughs Wellcome Co. Indolyl tetrahydropyridines for treating migraine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
US, 5037845 А (Glaxo groop Limited), 06.08.91, A 61 K 31/40. EP, 0303507 А2 (Glaxo Groop Limited),15.02.89, A 61 K 31/445. SU, 1498386 А3 (Глексо Групп лимитед), C 07 D 209/16, 30.07.89. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2423360C2 (ru) * 2005-10-14 2011-07-10 Атерсис, Инк. Производные индола как ингибиторы н3-рецептора гистамина для лечения когнитивных расстройств и нарушений сна, ожирения и других расстройств центральной нервной системы

Also Published As

Publication number Publication date
OA10109A (en) 1996-12-18
GB9209882D0 (en) 1992-06-24
CH685920A5 (fr) 1995-11-15
HK95697A (en) 1997-08-08
CY2039B1 (en) 1998-04-30
NO944214L (no) 1994-11-07
IE75203B1 (en) 1997-08-27
IL105468A (en) 1998-09-24
TW231970B (enExample) 1994-10-11
DE69317418T2 (de) 1998-07-30
GB2266665A (en) 1993-11-10
DE69317418D1 (de) 1998-04-16
SG46649A1 (en) 1998-02-20
HU211638A9 (en) 1995-12-28
BR1100108A (pt) 1999-12-07
WO1993021916A1 (en) 1993-11-11
KR100253111B1 (en) 2000-07-01
ZA933178B (en) 1994-01-10
RO112993B1 (ro) 1998-03-30
BE1007024A5 (fr) 1995-02-21
IE930339A1 (en) 1993-11-17
NZ252132A (en) 1996-09-25
IT1261471B (it) 1996-05-23
GR3026584T3 (en) 1998-07-31
EP0639072B1 (en) 1998-03-11
NO944214D0 (no) 1994-11-04
FR2690847A1 (fr) 1993-11-12
JPH07506570A (ja) 1995-07-20
CA2135179A1 (en) 1993-11-11
IL105468A0 (en) 1993-08-18
FR2690847B1 (fr) 1995-06-09
CA2135179C (en) 2000-12-05
BG99167A (bg) 1995-06-30
CZ283512B6 (cs) 1998-04-15
AU670083B2 (en) 1996-07-04
NO306700B1 (no) 1999-12-13
BG62120B1 (bg) 1999-03-31
US5705506A (en) 1998-01-06
HU227338B1 (en) 2011-04-28
EP0639072A1 (en) 1995-02-22
GB2266665B (en) 1996-05-22
ITRM930286A1 (it) 1994-11-06
UA37206C2 (uk) 2001-05-15
ATE163850T1 (de) 1998-03-15
ITRM930286A0 (it) 1993-05-06
HUT71418A (en) 1995-11-28
ES2113533T3 (es) 1998-05-01
AU4064093A (en) 1993-11-29
CZ272394A3 (en) 1995-10-18
GB9309209D0 (en) 1993-06-16

Similar Documents

Publication Publication Date Title
RU2118527C1 (ru) Фармацевтическая композиция, содержащая алкилсульфонамид-агонист 5ht1, для ректального введения
Davies et al. Misoprostol therapeutics revisited
JP2000507544A (ja) 痛みの治療方法
HUP0302362A2 (hu) Fejfájás, migrén, émelygés és hányás kezelésére alkalmas gyógyászati készítmény
RU2160101C2 (ru) Средство для лечения десинхронизационных нарушений, фармацевтическая композиция
CZ288835B6 (cs) Farmaceutický prostředek k ošetřování poruch spánku
JP2965703B2 (ja) 直腸用組成物
JPS624224A (ja) 鎮痛剤、解熱剤または抗炎症剤を含む坐剤
AU3810100A (en) Stable pharmaceutical application form for paroxetin anhydrate
JPH11507671A (ja) 良性前立腺過形成を処置するためのメラトニンアゴニスト
CA2136845A1 (en) Pharmaceutical compositions comprising 5-ht1 receptor agonists and absorption enhancers
MXPA97010075A (en) Melatonine agonists for the treatment in prostatic hyperplasia beni

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20040504